StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the medical research company’s stock. Check-Cap Price Performance NASDAQ CHEK opened at $2.29 on Tuesday. Check-Cap has a 1 year low of $1.27 and a 1 year […] Read this story
